JP2006316072A5 - - Google Patents

Download PDF

Info

Publication number
JP2006316072A5
JP2006316072A5 JP2006222713A JP2006222713A JP2006316072A5 JP 2006316072 A5 JP2006316072 A5 JP 2006316072A5 JP 2006222713 A JP2006222713 A JP 2006222713A JP 2006222713 A JP2006222713 A JP 2006222713A JP 2006316072 A5 JP2006316072 A5 JP 2006316072A5
Authority
JP
Japan
Prior art keywords
sequences
isolates
patients
series
adjacent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006222713A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006316072A (ja
Filing date
Publication date
Priority claimed from US08/187,879 external-priority patent/US6841381B1/en
Application filed filed Critical
Publication of JP2006316072A publication Critical patent/JP2006316072A/ja
Publication of JP2006316072A5 publication Critical patent/JP2006316072A5/ja
Withdrawn legal-status Critical Current

Links

JP2006222713A 1994-01-27 2006-08-17 Dna転写ユニットの接種による免疫化 Withdrawn JP2006316072A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/187,879 US6841381B1 (en) 1992-03-23 1994-01-27 Immunization by inoculation of DNA transcription unit

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP52014295A Division JP4050310B2 (ja) 1994-01-27 1995-01-25 Dna転写ユニットの接種による免疫化

Publications (2)

Publication Number Publication Date
JP2006316072A JP2006316072A (ja) 2006-11-24
JP2006316072A5 true JP2006316072A5 (cg-RX-API-DMAC7.html) 2007-05-24

Family

ID=22690873

Family Applications (2)

Application Number Title Priority Date Filing Date
JP52014295A Expired - Fee Related JP4050310B2 (ja) 1994-01-27 1995-01-25 Dna転写ユニットの接種による免疫化
JP2006222713A Withdrawn JP2006316072A (ja) 1994-01-27 2006-08-17 Dna転写ユニットの接種による免疫化

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP52014295A Expired - Fee Related JP4050310B2 (ja) 1994-01-27 1995-01-25 Dna転写ユニットの接種による免疫化

Country Status (7)

Country Link
EP (2) EP1170368B1 (cg-RX-API-DMAC7.html)
JP (2) JP4050310B2 (cg-RX-API-DMAC7.html)
AT (1) ATE475668T1 (cg-RX-API-DMAC7.html)
CA (1) CA2181832C (cg-RX-API-DMAC7.html)
DE (1) DE69536091D1 (cg-RX-API-DMAC7.html)
ES (1) ES2348013T3 (cg-RX-API-DMAC7.html)
WO (1) WO1995020660A2 (cg-RX-API-DMAC7.html)

Families Citing this family (81)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643578A (en) 1992-03-23 1997-07-01 University Of Massachusetts Medical Center Immunization by inoculation of DNA transcription unit
US6165993A (en) * 1992-03-23 2000-12-26 University Of Massachusetts Medical Center DNA vaccines against rotavirus infections
US5620896A (en) * 1992-03-23 1997-04-15 University Of Massachusetts Medical Center DNA vaccines against rotavirus infections
US6127116A (en) * 1995-08-29 2000-10-03 Washington University Functional DNA clone for hepatitis C virus (HCV) and uses thereof
US6270795B1 (en) 1995-11-09 2001-08-07 Microbiological Research Authority Method of making microencapsulated DNA for vaccination and gene therapy
GB9709900D0 (en) * 1997-05-15 1997-07-09 Microbiological Res Authority Microencapsulated DNA for vaccination and gene therapy
EP0965336A1 (en) * 1995-11-09 1999-12-22 Microbiological Research Authority Microencapsulated DNA for gene therapy
US5741492A (en) * 1996-01-23 1998-04-21 St. Jude Children's Research Hospital Preparation and use of viral vectors for mixed envelope protein vaccines against human immunodeficiency viruses
US6723558B1 (en) 1996-01-23 2004-04-20 St. Jude Children's Research Hospital Preparation and use of viral vectors for mixed envelope protein vaccines against human immunodeficiency viruses
AU2118997A (en) * 1996-02-05 1997-08-22 Johns Hopkins University, The Measles immunization by dna transcription unit inoculation
US6534312B1 (en) 1996-02-22 2003-03-18 Merck & Co., Inc. Vaccines comprising synthetic genes
ATE309366T1 (de) * 1996-02-22 2005-11-15 Merck & Co Inc Synthetische hiv-gene
AU728422B2 (en) * 1996-06-21 2001-01-11 Merck & Co., Inc. Vaccines comprising synthetic genes
AU3514197A (en) 1996-07-03 1998-01-21 Genetics Institute Inc. Protease fmh-1, an ice/ced-like protease
FR2751225B1 (fr) 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique aviaire
FR2751223B1 (fr) 1996-07-19 1998-12-04 Rhone Merieux Formule de vaccin polynucleotidique felin
FR2751228B1 (fr) 1996-07-19 1998-11-20 Rhone Merieux Vaccin polynucleotidique bovin pour voie intradermique
FR2751227B1 (fr) 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique contre les pathologies canines, notamment les pathologies respiratoires et digestives
US7294338B2 (en) 1996-07-19 2007-11-13 Merial Polynucleotide vaccine formula against canine pathologies, in particular respiratory and digestive pathologies
FR2751229B1 (fr) * 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique notamment contre la pathologie respiratoire des bovins
FR2751224B1 (fr) * 1996-07-19 1998-11-20 Rhone Merieux Formule de vaccin polynucleotidique contre les pathologies respiratoires et de reproduction des porcs
FR2751226B1 (fr) * 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique contre les pathologies du cheval
US5783567A (en) * 1997-01-22 1998-07-21 Pangaea Pharmaceuticals, Inc. Microparticles for delivery of nucleic acid
US6696291B2 (en) 1997-02-07 2004-02-24 Merck & Co., Inc. Synthetic HIV gag genes
CN1044092C (zh) 1997-02-26 1999-07-14 上海医科大学 抗原-抗体-重组dna复合型疫苗
US7049428B1 (en) 1998-03-04 2006-05-23 Washington University HCV variants
US7338759B1 (en) 1997-03-04 2008-03-04 Washington University HCV variants
UA78180C2 (uk) 1997-10-03 2007-03-15 Меріаль Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти
US6517843B1 (en) 1999-08-31 2003-02-11 Merial Reduction of porcine circovirus-2 viral load with inactivated PCV-2
US6406719B1 (en) 1998-05-13 2002-06-18 Microbiological Research Authority Encapsulation of bioactive agents
GB9810236D0 (en) 1998-05-13 1998-07-08 Microbiological Res Authority Improvements relating to encapsulation of bioactive agents
WO1999065531A1 (en) 1998-06-18 1999-12-23 Johns Hopkins University School Of Medicine Polymers for delivery of nucleic acids
US6916490B1 (en) 1998-07-23 2005-07-12 UAB Research Center Controlled release of bioactive substances
GB9818627D0 (en) 1998-08-26 1998-10-21 Glaxo Group Ltd Improvements in dva vaccination
US6881723B1 (en) 1998-11-05 2005-04-19 Powderject Vaccines, Inc. Nucleic acid constructs
US7022320B1 (en) 1999-02-09 2006-04-04 Powderject Vaccines, Inc. Mycobacterium tuberculosis immunization
US7196066B1 (en) 1999-11-03 2007-03-27 Powderject Vaccines, Inc. DNA-vaccines based on constructs derived from the genomes of human and animal pathogens
US6852705B2 (en) 2000-01-21 2005-02-08 Merial DNA vaccines for farm animals, in particular bovines and porcines
US7078388B2 (en) 2000-01-21 2006-07-18 Merial DNA vaccines for farm animals, in particular bovines and porcines
AUPS054702A0 (en) 2002-02-14 2002-03-07 Immunaid Pty Ltd Cancer therapy
US6982156B2 (en) 2002-03-27 2006-01-03 Trustees Of The University Of Pennsylvania Compositions and methods modulating variola and vaccinia virus
US6783759B2 (en) 2002-03-27 2004-08-31 Trustees Of The University Of Pennsylvania Compositions and methods for modulating variola virus
WO2005035771A2 (en) 2003-10-10 2005-04-21 Powderject Vaccines, Inc. Nucleic acid constructs
BRPI0415533A (pt) 2003-10-24 2006-12-26 Immunaid Pty Ltd método de terapia
CN100549021C (zh) 2004-05-27 2009-10-14 森托科尔公司 猕猴前列腺特异性抗原
US20060121031A1 (en) 2004-12-07 2006-06-08 Mckenzie Brent S Relay vaccine
US8202967B2 (en) 2006-10-27 2012-06-19 Boehringer Ingelheim Vetmedica, Inc. H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use
MX2009012924A (es) 2007-06-08 2010-03-25 Australian Poultry Crc Pty Ltd Toxina clostridial netb.
WO2009026660A1 (en) 2007-08-30 2009-03-05 Walter And Eliza Hall Institute Of Medical Research Dendritic cell marker and uses thereof
DK2435825T3 (en) 2009-05-27 2015-10-19 Biotempus Ltd Modes for medical care
TWI627281B (zh) 2009-09-02 2018-06-21 百靈佳殷格翰家畜藥品公司 降低pcv-2組合物殺病毒活性之方法及具有改良免疫原性之pcv-2組合物
RU2578420C2 (ru) 2010-05-10 2016-03-27 Эсенд Байофармасьютикалз Пти Лтд Иммуностимулирующие и вакцинные композиции
AR083533A1 (es) 2010-10-22 2013-03-06 Boehringer Ingelheim Vetmed Proteinas de hemaglutinina 5 (h5) para el tratamiento y prevencion de las infecciones de gripe
AR088028A1 (es) 2011-08-15 2014-05-07 Boehringer Ingelheim Vetmed Proteinas h5, de h5n1 para un uso medicinal
WO2013033092A2 (en) 2011-09-03 2013-03-07 Boehringer Ingelheim Vetmedica Gmbh Streptococcus suis pilus antigens
JP2015504413A (ja) 2011-10-28 2015-02-12 パトリス リミテッド Pat−lm1エピトープおよびそれを使用するための方法
EP2958586B1 (en) 2013-02-21 2018-09-05 Boehringer Ingelheim Vetmedica GmbH H5 proteins of h5n1 influenza virus for use as a medicament
CA2943816A1 (en) 2014-04-03 2015-10-08 Boehringer Ingelheim Vetmedica, Inc. Porcine epidemic diarrhea virus vaccine
WO2016000022A1 (en) 2014-06-30 2016-01-07 Murdoch Childrens Research Institute Helicobacter therapeutic
EP3344289B1 (en) 2015-08-31 2020-01-29 Boehringer Ingelheim Vetmedica GmbH Pestivirus vaccines for congenital tremors
US20170072042A1 (en) 2015-09-16 2017-03-16 Boehringer Ingelheim Vetmedica, Inc. Salmonella choleraesuis-salmonella typhimurium vaccines
MX391049B (es) 2016-09-20 2025-03-21 Boehringer Ingelheim Vetmedica Gmbh Nuevos promotores
MX2019003161A (es) 2016-09-20 2019-05-27 Boehringer Ingelheim Vetmedica Gmbh Nuevo sitio de insercion orf70 de ehv.
ES2956050T3 (es) 2016-09-20 2023-12-12 Boehringer Ingelheim Vetmedica Gmbh Vectores de adenovirus caninos
UY37408A (es) 2016-09-20 2018-03-23 Boehringer Ingelheim Vetmedica Gmbh Vacuna de vectores contra el virus de la gripe “a” porcina
EP4570264A3 (en) 2016-11-03 2026-01-21 Boehringer Ingelheim Vetmedica GmbH Vaccine against porcine parvovirus
UA130511C2 (uk) 2016-11-03 2026-03-11 Бьорінгер Інгельхайм Ветмедіка Гмбх Вакцина проти свинячого парвовірусу й вірусу свинячого репродуктивного й респіраторного синдрому та спосіб її одержання
WO2018140766A2 (en) 2017-01-30 2018-08-02 Boehringer Ingelheim Vetmedica, Inc. Porcine coronavirus vaccines
JP7083362B2 (ja) 2017-07-12 2022-06-10 ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド セネカウイルスa免疫原性組成物およびその方法
MX2020003071A (es) 2017-09-23 2020-07-28 Boehringer Ingelheim Vetmedica Gmbh Sistema de expresion de paramyxoviridae.
WO2019092027A1 (en) 2017-11-09 2019-05-16 Boehringer Ingelheim Vetmedica Gmbh Sapelovirus immunogenic compositions and uses thereof
US11033616B2 (en) 2018-02-23 2021-06-15 Boehringer Ingelheim Vetmedica Gmbh Recombinant viral vector systems expressing exogenous feline paramyxovirus genes and vaccines made therefrom
JP7245260B2 (ja) 2018-03-19 2023-03-23 ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハー Ehv挿入部位ul43
CA3091954A1 (en) 2018-03-19 2019-09-26 Boehringer Ingelheim Vetmedica Gmbh New ehv with inactivated ul18 and/or ul8
CN119488586A (zh) 2018-03-26 2025-02-21 勃林格殷格翰动物保健美国有限公司 制备免疫原性组合物的方法
US11464852B2 (en) 2018-09-20 2022-10-11 Boehringer Ingelheim Vetmedica Gmbh Modified PEDV spike protein
EP3852800A1 (en) 2018-09-20 2021-07-28 Boehringer Ingelheim Vetmedica GmbH Intranasal vector vaccine against porcine epidemic diarrhea
WO2021158878A1 (en) 2020-02-06 2021-08-12 Boehringer Ingelheim Animal Health USA Inc. Polypeptides useful for detecting anti-rhabdovirus antibodies
CN116438202A (zh) 2020-10-05 2023-07-14 勃林格殷格翰动物保健美国有限公司 包含圆环病毒科衣壳蛋白的融合蛋白及其构成的嵌合病毒样颗粒
WO2022076979A1 (en) 2020-10-05 2022-04-14 Boehringer Ingelheim Vetmedica Gmbh Fusion protein useful for vaccination against rotavirus
JP2025511739A (ja) 2022-04-05 2025-04-16 ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハー ロタウイルスに対するワクチン接種のために有用な免疫原性組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU626288B2 (en) * 1988-02-05 1992-07-30 Commonwealth Scientific And Industrial Research Organisation Gene expression system (particularly for rotavirus vp7 protein) involving a foreign signal peptide and optionally a transmembrane anchor sequence
DK0737750T3 (da) * 1989-03-21 2003-09-01 Vical Inc Ekspression af exogene polynucleotidsekvenser i vertebrater
WO1993015763A1 (en) * 1992-02-18 1993-08-19 Smithkline Beecham Corporation Vaccinal polypeptides
US5643578A (en) * 1992-03-23 1997-07-01 University Of Massachusetts Medical Center Immunization by inoculation of DNA transcription unit
ATE295895T1 (de) * 1992-03-11 2005-06-15 Powderject Vaccines Inc Genetischer impfstoff gegen den immunschwäche virus
WO1993025235A1 (en) * 1992-06-09 1993-12-23 President And Fellows Of Harvard College Aids therapeutics based on hiv-2 vpx peptides

Similar Documents

Publication Publication Date Title
UA98784C2 (ru) Химические соединения, являющиеся ингибиторами ненуклеозидной обратной транскриптазы
JP2008543728A5 (cg-RX-API-DMAC7.html)
JP2009511485A5 (cg-RX-API-DMAC7.html)
JP2008542211A5 (cg-RX-API-DMAC7.html)
JP2009538387A5 (cg-RX-API-DMAC7.html)
JP2009506999A5 (cg-RX-API-DMAC7.html)
EA200601837A1 (ru) Бензоксазины для лечения заболеваний дыхательных путей
JP2008533230A5 (cg-RX-API-DMAC7.html)
JP2007231207A5 (cg-RX-API-DMAC7.html)
JP2009503140A5 (cg-RX-API-DMAC7.html)
JP2006063441A5 (cg-RX-API-DMAC7.html)
JP2007119645A5 (cg-RX-API-DMAC7.html)
JP2005095148A5 (cg-RX-API-DMAC7.html)
JP2007321035A5 (cg-RX-API-DMAC7.html)
JP2008538930A5 (cg-RX-API-DMAC7.html)
JP2005290409A5 (cg-RX-API-DMAC7.html)
JP2006101735A5 (cg-RX-API-DMAC7.html)
JP2006523255A5 (cg-RX-API-DMAC7.html)
JP2007190226A5 (cg-RX-API-DMAC7.html)
JP2009067933A5 (cg-RX-API-DMAC7.html)
JP2006273834A5 (cg-RX-API-DMAC7.html)
JP2009532551A5 (cg-RX-API-DMAC7.html)
JP2008524312A5 (cg-RX-API-DMAC7.html)
JP2007254440A5 (cg-RX-API-DMAC7.html)
JP2008500963A5 (cg-RX-API-DMAC7.html)